ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978

NCAB Commends Garb for His Contributions

December 11, 1981

In Brief: Panel To Select Breast Committee Forom 130 Nominations; Bristol Plans Move To Princeton

December 6, 1991

NCI-Approved Clinical Trials

January 27, 2006

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011